Corrigendum: Bridging the gap between in vitro and in vivo: Dose and schedule predictions for the ATR inhibitor AZD6738

Lignende værker

• Bridging the gap between in vitro and in vivo: Dose and schedule predictions for the ATR inhibitor AZD6738
  af: Checkley, Stephen, et al.
  Udgivet: (2015)
• Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei
  af: Dillon, Magnus T., et al.
  Udgivet: (2016)
• The ATR inhibitor AZD6738 synergizes with gemcitabine in vitro and in vivo to induce pancreatic ductal adenocarcinoma regression
  af: Wallez, Yann, et al.
  Udgivet: (2018)
• ATR kinase inhibitors NVP-BEZ235 and AZD6738 effectively penetrate the brain after systemic administration
  af: Fròsina, Guido, et al.
  Udgivet: (2018)
• ATR kinase inhibitor AZD6738 potentiates CD8(+) T cell–dependent antitumor activity following radiation
  af: Vendetti, Frank P., et al.
  Udgivet: (2018)